Labshake search

1 - 10 of 10 citations for Cow Putative Phospholipase B Like 2 PLBD2 ELISA Kit since 2019

• CD46 targeted ²¹²Pb alpha particle radioimmunotherapy for prostate cancer treatment

  Jun Li, et al., bioRxiv - Bioengineering 2023

  Quote: ... and p-SCN-Bn-TCMC (S-2-(4-Isothiocyanatobenzyl)-1,4,7,10-tetraaza-1,4,7,10-tetra(2-carbamoylmethyl)cyclododecane) (catalog No. B-1005) were purchased from Macrocyclics, Inc ...
• An immunoPET probe to SARS-CoV-2 reveals early infection of the male genital tract in rhesus macaques

  Patrick J. Madden, et al., bioRxiv - Immunology 2022

  Quote: ... DOTA-NHS-ester (#B-280, Macrocyclics) was dissolved in dimethyl sulfoxide (DMSO ...
• CUB domain containing protein 1 (CDPC1) is a target for radioligand therapy in castration resistant prostate cancer

  Ning Zhao, et al., bioRxiv - Cancer Biology 2021

  Quote: ... p-SCN-Bn-Deferoxamine (B-705) and p-SCN-Bn-DOTA (B-205) were purchased from Macrocyclics (Plano, TX) and directly used for conjugation without further purification to antibody ...
• CXCR4-binding PET tracers link monocyte recruitment and endothelial injury in murine atherosclerosis

  Osamu Baba, et al., bioRxiv - Pathology 2020

  Quote: ... DOTA-NHS-ester was purchased from Macrocyclics (product #: B-280). mPEG®15-amine was obtained from Quanta BioDesign ...
• Tissue-resident FOLR2⁺ macrophages associate with tumor-infiltrating CD8⁺ T cells and with increased survival of breast cancer patients

  Rodrigo Nalio Ramos, et al., bioRxiv - Immunology 2021

  Quote: ... DOTA-maleimide (DM)-linked metal barcodes were prepared by dissolving DM (Macrocyclics, Cat# B-272) in L buffer (MAXPAR ...
• CD46 targeted ²¹²Pb alpha particle radioimmunotherapy for prostate cancer treatment

  Jun Li, et al., bioRxiv - Bioengineering 2023

  Quote: YS5 was first conjugated with the bi-functional chelator 2-(4-isothiocyanotobenzyl)-1,4,7,10-tetraaza-1,4,7,10-tetra-(2-carbamoylmethyl)-cyclododecane (TCMC; Macrocyclics, Plano, TX) at the molar ratio of TCMC/YS5 at 10:1 ...
• A Machine Learning-optimized system for on demand, pulsatile, photo- and chemo-therapeutic treatment using near-infrared responsive MoS₂-based microparticles in a breast cancer model

  Maria Kanelli, et al., bioRxiv - Bioengineering 2023

  Quote: ... The particles are then incubated with PBS buffer with adjusted pH at 8.0 using 1 M dipotassium phosphate with the chelator p-SCN-Bn-Deferoxamine (B-705, Macrocyclics, Plano, TX, USA) overnight at 4 ℃ ...
• In Vivo Biorthogonal Antibody Click for Dual Targeting and Augmented Efficacy in Cancer Treatment

  Sandeep Surendra Panikar, et al., bioRxiv - Cancer Biology 2023

  Quote: ... The purified mAbs was then reacted with a 20-fold molar excess of 2-S-(4-Isothiocyanatobenzyl)-1,4,7-triazacyclononane-1,4,7-triacetic acid (p-SCN-Bn-NOTA, Macrocyclics) overnight at 4 °C with gentle agitation ...
• Supramolecular Organization Predicts Protein Nanoparticle Delivery to Neutrophils for Acute Lung Inflammation Diagnosis and Treatment

  Jacob W. Myerson, et al., bioRxiv - Bioengineering 2020

  Quote: Lysozyme-dextran nanogels were prepared for chelation to 111In by conjugation to S-2-(4-Isothiocyanatobenzyl)-1,4,7,10-tetraazacyclododecane tetraacetic acid (p-SCN-Bn-DOTA, Macrocyclics). Nanogels were moved to metal free pH 8.3 1 M NaHCO3 buffer by three-fold centrifugation (16000xg for 15 minutes ...
• An Inflammatory Clock Predicts Multi-morbidity, Immunosenescence and Cardiovascular Aging in Humans

  Nazish Sayed, et al., bioRxiv - Immunology 2019

  Quote: ... The cells were resuspended in 100 uL PBS buffer containing 2 ug/mL Live-Dead (DOTA-maleimide (Macrocyclics) containing natural-abundance indium) ...